Jasper Therapeutics, Inc.
JSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $312 | $82 | $18 | $89 |
| - Cash | $72 | $87 | $38 | $85 |
| + Debt | $2 | $3 | $4 | $3 |
| Enterprise Value | $242 | -$2 | -$17 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$75 | -$68 | -$50 | -$36 |
| % Margin | – | – | – | – |
| Net Income | -$71 | -$64 | -$38 | -$31 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.89 | -6.18 | -10.33 | -26.89 |
| % Growth | 20.9% | 40.2% | 61.6% | – |
| Operating Cash Flow | -$63 | -$52 | -$46 | -$34 |
| Capital Expenditures | -$1 | -$0 | -$1 | -$2 |
| Free Cash Flow | -$63 | -$52 | -$46 | -$36 |